| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 9,376,000 | 8,770,000 | 7,213,000 | 7,720,000 | | Cost of Revenue | 6,426,000 | 5,956,000 | 5,349,000 | 5,115,000 | | | Gross Profit | 2,950,000 | 2,814,000 | 1,864,000 | 2,605,000 | | | Operating Expenses | | Research Development | 360,000 | 330,000 | 359,000 | 332,000 | | Selling General and Administrative | 987,000 | 934,000 | 852,000 | 797,000 | | Non Recurring |
-
|
-
|
-
| 25,000 | | Others |
-
|
-
| 50,000 | 53,000 | | | | Total Operating Expenses |
-
|
-
|
-
| 1,207,000 | | | | Operating Income or Loss | 1,603,000 | 1,550,000 | 603,000 | 1,398,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (179,000) |
-
|
-
| (631,000) | | Earnings Before Interest And Taxes | 1,506,000 | 1,550,000 | 603,000 | 743,000 | | Interest Expense | 94,000 | 80,000 | 110,000 | 113,000 | | Income Before Tax | 1,412,000 | 1,470,000 | 493,000 | 630,000 | | Income Tax Expense | 335,000 | 273,000 | (54,000) | 102,000 | | Minority Interest | 1,000 | (6,000) | (2,000) | (2,000) | | | | Net Income From Continuing Ops | 1,078,000 | 1,191,000 | 545,000 | 526,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,078,000 | 1,191,000 | 545,000 | 526,000 | | Preferred Stock And Other Adjustments | (5,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,073,000 | $1,191,000 | $545,000 | $526,000 |
|
7.87% Nasdaq 
Income Statement
